Abstract:Background Cancer-associated fibroblasts (CAFs) play a significant role in regulating the clinical outcome and radiotherapy prognosis of prostate cancer (PCa). The aim of this study is to identify CAFs-related genes (CAFsRGs) using single-cell analysis and evaluate their potential for predicting the prognosis and radiotherapy prognosis in PCa. Methods We acquire transcriptome and single-cell RNA sequencing (scRNA-seq) results of PCa and normal adjacent tissues from The GEO and TCGA databases. The "MCPcounter" and "EPIC" R packages were used to assess the infiltration level of CAFs and examine their correlation with PCa prognosis. ScRNA-seq and differential gene expression analyses were used to extract CAFsRGs. We also applied COX and LASSO analysis to further construct a risk score (CAFsRS) to assess biochemical recurrence-free survival (BRFS) and radiotherapy prognosis of PCa. The predictive efficacy of CAFsRS was evaluated by ROC curves and subgroup analysis. Finally, we integrated the CAFsRS gene signature with relevant clinical features to develop a nomogram, enhancing the predictive accuracy. Results The abundance of CAFs is associated with a poor prognosis of PCa patients. ScRNA-seq and differential gene expression analysis revealed 323 CAFsRGs. After COX and LASSO analysis, we obtained seven CAFsRGs with prognostic significance (PTGS2, FKBP10, ENG, CDH11, COL5A1, COL5A2, and SRD5A2). Additionally, we established a risk score model based on the training set (n = 257). The ROC curve was used to confirm the performance of CAFsRS (The AUC values for 1, 3 and 5-year survival were determined to be 0.732, 0.773, and 0.775, respectively.). The testing set (n = 129), GSE70770 set (n = 199) and GSE116918 set (n = 248) revealed that the model exhibited exceptional predictive performance. This was also confirmed by clinical subgroup analysis. The violin plot demonstrated a statistically significant disparity in the CAFs infiltrations between the high-risk and low-risk groups of CAFsRS. Further analysis confirmed that both CAFsRS and T stage were independent prognostic factors for PCa. The nomogram was then established and its excellent predictive performance was demonstrated through calibration and ROC curves. Finally, we developed an online prognostic prediction app ( https://sysu-symh-cafsnomogram.streamlit.app/ ) to facilitate the practical application of the nomogram. Conclusions The prognostic prediction risk score model we constructed could accurately predict BRFS and radiotherapy prognosis PCa, which can provide new ideas for clinicians to develop personalized PCa treatment and follow-up programs.

Comprehensively Analysis of Splicing Factors to Construct Prognosis Prediction Classifier in Prostate Cancer.

Study of prognostic splicing factors in cancer using machine learning approaches

Comprehensive Analysis of Alternative Splicing Profiling Reveals Novel Events Associated with Prognosis and the Infiltration of Immune Cells in Prostate Cancer.

Systematic Profiling of Alternative Splicing Signature Reveals Prognostic Predictor for Prostate Cancer

Comprehensive Analysis of Splicing Factor and Alternative Splicing Event to Construct Subtype-Specific Prognosis-Predicting Models for Breast Cancer

Comprehensive Analysis of Prognostic Alternative Splicing Signatures in Oral Squamous Cell Carcinoma

Single-nucleotide Polymorphisms of Stemness Genes Predicted to Regulate RNA Splicing, Microrna and Oncogenic Signaling Are Associated with Prostate Cancer Survival.

Integrative analysis reveals the prognostic value and functions of splicing factors implicated in hepatocellular carcinoma

Identification of Prognostic Alternative Splicing Signature in Breast Carcinoma.

Screening Gene Expression-Related Alternative Splicing Event Signature for Colon Cancer Prognostic Prediction

Integrated Multi-Omics Analysis of the Clinical Relevance and Potential Regulatory Mechanisms of Splicing Factors in Hepatocellular Carcinoma.

Comprehensive Profiling of Aberrant Prognostic Alternative Splicing Signatures in Clear Cell Renal Cell Carcinoma: a Retrospective Study Based on Large-Scale Sequencing Data

Prognostic Value of Survival-Associated Splicing Factor SNRPA1 Overexpression and Its Potential Mechanism in Liver Cancer

Systematic analysis of the relationship between ovarian cancer prognosis and alternative splicing

Identification of Bone Metastatic and Prognostic Alternative Splicing Signatures in Prostate Adenocarcinoma

Single-cell Analysis Extracted CAFs-related Genes to Established Online App to Predict Clinical Outcome and Radiotherapy Prognosis of Prostate Cancer

Comprehensive Analysis of Prognostic Alternative Splicing Signature Reveals Recurrence Predictor for Papillary Thyroid Cancer

Identification of Splicing Factors Signature Predicting Prognosis Risk and the Mechanistic Roles of Novel Oncogenes in HNSCC

Senescence-associated Secretory Phenotype Constructed Detrimental and Beneficial Subtypes and Prognostic Index for Prostate Cancer Patients Undergoing Radical Prostatectomy

Comprehensive analysis and establishment of a prediction model of alternative splicing events reveal the prognostic predictor and immune microenvironment signatures in triple negative breast cancer

Intron retention is a hallmark and spliceosome represents a therapeutic vulnerability in aggressive prostate cancer